Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKesson
Colorcon
AstraZeneca
Baxter
Harvard Business School
McKinsey

Last Updated: November 14, 2019

DrugPatentWatch Database Preview

Litigation Details for Takeda Pharmaceutical Company Limited v. Mylan, Inc. (S.D.N.Y. 2012)

See Plans and Pricing

« Back to Dashboard

Takeda Pharmaceutical Company Limited v. Mylan, Inc. (S.D.N.Y. 2012)

Docket   Start Trial Date Filed 2012-01-03
Court District Court, S.D. New York Date Terminated 2014-02-26
Cause 35:271 Patent Infringement Assigned To Denise Cote
Jury Demand None Referred To Ronald L. Ellis
Parties ANDRX LABS, LLC; MYLAN PHARMACEUTICALS, INC.; MYLAN, INC.; TAKEDA GLOBAL RESEARCH AND DEVELOPMENT CENTER, INC.; TAKEDA PHARMACEUTICAL COMPANY LIMITED; TAKEDA PHARMACEUTICALS NORTH AMERICA, INC.; WATSON PHARMACEUTICALS, INC.
Patents 5,965,584; 6,099,859; 6,166,043; 6,172,090; 6,495,162; 6,866,866; 7,785,627; 7,959,946
Attorneys Adam Phillip Samansky; Andre K. Cizmarik; Anthony Joseph Viola; Ariana Chung-Han; Barbara L. Moore; David Cotta; David G. Conlin; Elham Firouzi Steiner; Gary E Hood; Graham L.W. Day; Jason A. Nagi; Karen M Zelle; Kathleen B. Carr; Keith J. Grady; Kirin K. Gill; Mark Thomas Deming; Matthew J Bresnahan; Matthew R Reed; Michael S Sommer; Peter John Cuomo; Richard Juang; Robyn H Ast; Thomas Hoelder Wintner; Tonia Maria Ouellette Klausner; Tung-On Kong; Wendy Lynn Devine; Zachary Winthrop Silverman
Firms Edwards Angell Palmer & Dodge LLP; Edwards Wildman Palmer LLP; Edwards Wildman Palmer, LLP-MA; Locke Lord LLP (NYC); Polsinelli Shughart; Polsinelli Shughart P.C. (NY); Polsinelli Shughart PC; Wilson Sonsini Goodrich & Rosati (CA); Wilson Sonsini Goodrich & Rosati, P.C.; Wilson Sonsini Goodrich & Rosati, P.C. (San Diego); Wilson Sonsini Goodrich & Rosati( 1301 Ave. of the Americas); Wilson, Sonsini, Goodrich & Rosati P.C.
Link to Docket External link to docket
Small Molecule Drugs cited in Takeda Pharmaceutical Company Limited v. Mylan, Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Takeda Pharmaceutical Company Limited v. Mylan, Inc. (S.D.N.Y. 2012)

Date Filed Document No. Description Snippet Link To Document
2012-01-03 1 Complaint United States Patent No. 6,099,859 (“the ‘859 patent”), entitled “Controlled Release Oral Tablet Having a…the ‘859 patent, ‘162 patent, ‘459 patent, ‘866 patent, ‘627 patent, ‘1 16 patent and ‘946 patent (collectively…under the ‘584 patent, the ‘043 patent, and the ‘090 patent (collectively, “Takeda Patents”). 20. United…licensed under the ‘584 patent, ‘043 patent and ‘090 patent (collectively, “Takeda Patents”) in connection with…Venue l. This is an action for patent infringement arising under the patent laws of the United States, Title External link to document
2012-10-11 75 Memorandum & Opinion in any event that the 1 United States Patents No. 5,965,584, 6,166,043, 6,172,090, 6,099,859, 6,495,…claims in two patents: the ‘859 and ‘162 Patents. A. The Specifications of the Six Patents Mylan…” The patents proceed to describe this as “limited research.” ‘946 Patent, 1:62-66; ‘627 Patent, 1:59-…appears in the ‘459, ‘866, and ‘162 Patents (‘459 Patent, 3:5-7; ‘866 Patent, 3:3-5; ‘162, 2:16-19). The following…for two of the patents, and in other sections of the specifications for all six patents. The only portion External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Moodys
AstraZeneca
Boehringer Ingelheim
Baxter
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.